TNFSF13B and myeloid sarcoma: Surprisingly, the previously identified risk allele for both MS and SLE of TNFSF13B (GCTGT>A) is linked to increased numbers of circulating B cells and drastically increased levels of soluble BAFF, as well as increased antibody production (75).